GlyConnect

Export CSV

Site	Core / Type	Composition	Biological associations
Asn-177	N-Linked / Complex	Hex:4 HexNAc:4	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11495 Composition Hex:4 HexNAc:4 (avg mass : 1479.3649 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Complex	Hex:5 HexNAc:4 dHex:1 NeuAc:2	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11516 Composition Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Complex	Hex:3 HexNAc:4 dHex:1	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11548 Composition Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / High-Mannose	Hex:6 HexNAc:2	taxonomy (1) protein (1) source (7) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / High-Mannose / Structure 11552 Composition Hex:6 HexNAc:2 (avg mass : 1397.2597 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Complex	Hex:4 HexNAc:3 NeuAc:1	taxonomy (1) protein (1) source (1) structure (1) composition (1) disease (0) reference (1) site (1) peptide (1) Taxonomy Homo sapiens (Human) Protein Source SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11561 Composition Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Complex	Hex:5 HexNAc:4 dHex:1	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11589 Composition Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Complex	Hex:4 HexNAc:3 dHex:1 NeuAc:1	taxonomy (1) protein (1) source (5) structure (1) composition (1) disease (0) reference (1) site (1) peptide (2) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO-S (CVCL_7183) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11607 Composition Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / High-Mannose	Hex:5 HexNAc:2	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / High-Mannose / Structure 11663 Composition Hex:5 HexNAc:2 (avg mass : 1235.1173 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Hybrid	Hex:5 HexNAc:3	taxonomy (1) protein (1) source (6) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Hybrid / Structure 11708 Composition Hex:5 HexNAc:3 (avg mass : 1438.3123 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Hybrid	Hex:5 HexNAc:3 dHex:1	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Hybrid / Structure 11711 Composition Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / High-Mannose	Hex:4 HexNAc:2	taxonomy (1) protein (1) source (3) structure (1) composition (1) disease (0) reference (1) site (1) peptide (1) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) HEK293 (CVCL_0045) SK-BR-3 (CVCL_0033) Reported structure N-Linked / High-Mannose / Structure 11727 Composition Hex:4 HexNAc:2 (avg mass : 1072.9749 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Hybrid	Hex:6 HexNAc:3 dHex:1 NeuAc:1	taxonomy (1) protein (1) source (6) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Hybrid / Structure 11733 Composition Hex:6 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 2037.8556 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Undefined core	Hex:4 HexNAc:3 dHex:1	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Undefined core / Structure 11764 Composition Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / High-Mannose	Hex:8 HexNAc:2	taxonomy (1) protein (1) source (7) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / High-Mannose / Structure 11800 Composition Hex:8 HexNAc:2 (avg mass : 1721.5445 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Hybrid	Hex:6 HexNAc:3	taxonomy (1) protein (1) source (6) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Hybrid / Structure 11818 Composition Hex:6 HexNAc:3 (avg mass : 1600.4547 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Complex	Hex:3 HexNAc:3	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11872 Composition Hex:3 HexNAc:3 (avg mass : 1114.0275 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Complex	Hex:3 HexNAc:4	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11887 Composition Hex:3 HexNAc:4 (avg mass : 1317.2225 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Hybrid	Hex:5 HexNAc:3 NeuAc:1	taxonomy (1) protein (1) source (2) structure (1) composition (1) disease (0) reference (1) site (1) peptide (1) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Hybrid / Structure 11889 Composition Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Complex	Hex:4 HexNAc:4 dHex:1	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11895 Composition Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / High-Mannose	Hex:7 HexNAc:2	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / High-Mannose / Structure 11946 Composition Hex:7 HexNAc:2 (avg mass : 1559.4021 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens
Asn-177	N-Linked / Complex	Hex:5 HexNAc:4 dHex:1 NeuAc:1	taxonomy (1) protein (1) source (8) structure (1) composition (1) disease (0) reference (1) site (1) peptide (3) Taxonomy Homo sapiens (Human) Protein Source BT-474 (CVCL_0179) CHO (CVCL_0213) CHO-S (CVCL_7183) Detroit 551 (CVCL_2434) HEK293 (CVCL_0045) HT-1080 (CVCL_0317) MCF-7 (CVCL_0031) SK-BR-3 (CVCL_0033) Reported structure N-Linked / Complex / Structure 11963 Composition Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 ) Disease Reference Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness. (2020 - Brücher D, Franc V, Smith SN, Heck AJR, Plückthun A) / Status : Reviewed Reported glycosite Mass spectrometry observed peptide PREEQFNSTYR (11aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens EEQFNSTYR (9aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens TKPREEQFNSTYR (13aa) Asn-177 Immunoglobulin heavy constant gamma 4 (nivolumab) / Homo sapiens